Alison Holmes, Jonathan Otter

Slides:



Advertisements
Similar presentations
Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.
Advertisements

1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :
Case discussion Michael Gardam University Health Network.
APIC Chapter 13 Journal Club April 15, 2015
Implementing Surgical Surveillance with icnet ng.
Infection Control- Issues in the Community Dr Yimmy Chow Interim Director and Consultant in Communicable Disease Control NW London Health Protection Team,
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
New Approach to Controlling Superbugs Virtual Learning Session 3 Data – Measuring Progress.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
Infection Prevention and Control Mandatory Update for Clinical Staff 2014.
One Healthcare System’s Response to the Chaos Swedish Health Services Swedish Medical Centers: Ballard, Cherry Hill, Edmonds, First Hill, & Issaquah Ambulatory.
European Centre for Disease Prevention and Control
NOROVIRUS OUTBREAK IN A UNIVERSITY TEACHING HOSPITAL O Meara M, O Connor M, Dept of Public Health, Dr. Steevens Hospital Background On March 7th 2006,
MRSA on Ward 29 University Hospital Aintree (UHA) April 2006-August 2010 Zoe Greenwood February 2011.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog:
Title of the Change Project
Title of the Change Project
Antibiotics: handle with care!
World Health Organization
Point Prevalence Survey in a Long Term Care Facility, 2016
Outbreak Investigations
Utah Zika investigation, July 2016
CRE prevalence among patients with no prior history of carriage
HELP US TO PREVENT INFECTIONS SPREADING
Screening for CPE: sensitivity of serial admission screens
Who’s carrying CPE? Universal admission screening in London
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies,
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Carbapenemase-Producing Enterobacteriacea
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Counting the cost and value of hospital cleaning and disinfection
Carbapenem-resistant Gram-negative bacteria
Changes to 10A NCAC 41A May 5, 2018.
Chapter 1: Introduction to Multidrug – Resistant Organisms
Cost utility of alternative Carbapenemase
Preventing VTE in hospitalised patients
Fast and expensive or cheap and slow
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
Hospital Antibiotic Stewardship Programs
Measuring and improving compliance with risk-factor based CPE admission screening Siddharth Mookerjee,1 Kate Martin, 1 Itziar Atucha-Zambrano, 1 Rebecca.
AMR: a clinical perspective
CPE: coming to a hospital near you!
“Can I swab your rectum please
Carbapenemase-Producing Enterobacteriacea
Detecting and managing CPE outbreaks: seek and you shall find
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective  J.A. Otter, P. Burgess,
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Microbiology and Infection prevention and control
TRAINING PRESENTATION
Health Protection Surveillance Centre
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Fighting MDR G-Negative Infections
Presentation transcript:

Alison Holmes, Jonathan Otter Risk factors for patients with carbapenemase-producing Enterobacteriaceae (CPE) at Imperial College Healthcare NHS Trust, 2014 – 2015 Siddharth Mookerjee, Jonathan Sullivan, Frances Davies, Hugo Donaldson, Eimear Brannigan, Alison Holmes, Jonathan Otter Jon.Otter@imperial.nhs.uk

What’s this talk about? Introduction Methods: What we did at Imperial Let’s talk CPE!! European picture Methods: What we did at Imperial Live surveillance Analysis Summary What did we learn?

Why do they pose a threat? What are CPEs? Anyone? C – Carbapenemase P – Producing E – Enterobacteriaceae CPO! CRE! CRO?! Why do they pose a threat? Key resistance mechanisms acquired – HGT Establish community reservoir – asymptomatic carriage Prior hospital stay – key risk factor Large at-risk group Carbapenem resistance conferred by carbapenemase production, ESBL –encoding genes, AmpC

European picture Carbapenemase-producing Enterobacteriaceae (CPE) present an important and emerging threat to healthcare facilities worldwide (Schwaber MJ et al . Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention) The prompt identification and subsequent isolation of CPE carriers is vital to preventing the transmission of CPE (Schwaber MJ et al . Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention) Risk factors for CPE include hospitalisation abroad, but the role of overseas travel or residence without direct healthcare contact, and the important of hospitalisation in the UK are less certain (ECDC. Risk assessment on the spread of Carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm, ECDC. 2011) Enterobacteriaceae are fermentative GNB, who with a combination of inherent and primarily acquired antibiotic resistant mechanisms are responsible for increased mortality among patients in acute care settings (Schwaber MJ, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028–33.) Recent situation report from PHE (PHE. Level 3 Situation Report 4: Carbapenemase Resistant Enterobacteriacaea. June 2015) noted that in Q4 of 2014, 71% of CRE were from patients in NHS Trusts. And reflecting the important of CPE – PHE have launched the Enhanced Surveillance system for Carbapenemase-producing Gram-negative bacteria. ECDC

Methods: What we did at Imperial Live surveillance system established in May 2014 56 positive CPO isolates (May 14 – Mar 15) 43 patients Enterobacteriaceae 38 isolates 28 patients Non – fermenters 18 isolates 15 patients

Previous hospitalisation within UK/abroad Travel abroad Patient hospital number PHE reference no DOB Previous hospitalisation within UK/abroad Travel abroad Gender Ward location where specimen taken VNTR Patient name Specimen collection date Isolate Ethnicity Co-morbidities, hospital diagnosis High dependency care history Molecular mechanism MICROBIOLOGY results fed LIVE to INFECTION CONTROL server + send sample to PHE lab MICROBIOLOGY informing INFECTION CONTROL TEAM We began recording detailed risk factor information for each new case of CPE from May 2014 to April 2015. Risk factors included, within the year prior to the first CPE specimen, hospitalisation abroad, travel abroad without hospitalisation, hospitalisation in the UK, and known epidemiological contact with another CPE case.  Microbiology sent out emails to Infection control team of high suspect cases of CRE, detailing patient current ward location, specimen detail (whether screen or clinical sample), specimen number, patient number, confirmation of in-house PCR result (confirm what is done in-house) Microbiology sent sample to PHE AMRHAI (confirm what exactly is done at PHE). Infection control team commencing gathering of risk factor information for that patient – awaiting confirmation as CPE Once PHE send confirmation of mechanism by which Carbapenemase resistant – then confirmed as a CPE All details stored on a centrally available database New software programmes like ICNET can do this for you Sample type Lab number for specimen

Distribution of CPO (May-14 to Mar-15) – based on 56 isolates, as per slide 5

Distribution of CPE by isolate and mechanism of resistance May 14 to Mar 15 – 38 CPE – as per slide 5

Comparison of risk factors – Enterobacteriaceae vs. Non-fermenters May 14 – Mar 15 – 38 isolates CPE – 28 patients – 25 on which RF information available May 14 – Mar 15 - 18 isolates NF – 15 patients – 12 on which RF information available Detailed risk factor data was not available for all patients.

K. pneumoniae NDM outbreak Most of the CPE isolates were K. pneumoniae, with either OXA-48 or NDM carbapenemases, in line with other UK hospitals. 88% of 25 CPE patients for whom risk factor data was available had one or more of the risk factors that we recorded. It was notable that more than half of the patients had been hospitalised in the UK and 12% had been hospitalised abroad, supporting previous findings that hospitalisation is the most important risk factor for CPE. A greater understand of CPE risk factors is crucial for developing effective and efficient screening strategies Add to notes – Ask Jon about key points we learnt from the outbreak – note the Live surveillance system helped us identify an outbreak of Kleb NDM at a couple of wards at Imperial Implementation of CRE screening Live surveillance Getting those side rooms up and ready Staff awareness Key linkages between microbiology infection control and staff on the wards Epi curve in the right direction Equals an Epi curve going in the right direction!

Summary: What did we learn? CPE are emerging at ICHT We experienced a clonal outbreak in the background of sporadic cases Sporadic cases have the ‘classic’ CPE risk factors (related to overseas travel etc), which do not seem to be shared by non-fermenters Real-time surveillance proved used in detecting and tracking the outbreak and wider CPE picture at ICHT Most of the CPE isolates were K. pneumoniae, with either OXA-48 or NDM carbapenemases, in line with other UK hospitals. 88% of 25 CPE patients for whom risk factor data was available had one or more of the risk factors that we recorded. It was notable that more than half of the patients had been hospitalised in the UK and 12% had been hospitalised abroad, supporting previous findings that hospitalisation is the most important risk factor for CPE. A greater understand of CPE risk factors is crucial for developing effective and efficient screening strategies Add to notes – Ask Jon about key points we learnt from the outbreak – note the Live surveillance system helped us identify an outbreak of Kleb NDM at a couple of wards at Imperial Implementation of CRE screening Live surveillance Getting those side rooms up and ready Staff awareness Key linkages between microbiology infection control and staff on the wards Epi curve in the right direction

Imperial researchers at IPS Oral presentations Abstract ID: 3865 - Otter J, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Girdham S, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Goldenberg S. Who’s carrying CRE? Universal admission screening in London Abstract ID: 3866 - Dyakova E, Bisnauthsing K, Querol-Rubiera A, Girdham S, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Goldenberg S, Otter J. “Can I swab your rectum, please?”: Improving compliance with rectal screening for CRE Abstract ID: 3860 - Mookerjee S, Sullivan J, Davies F, Donaldson H, Brannigan E, Holmes A, Otter J. Risk factors for patients with carbapenemase-producing Enterobacteriaceae (CPE) in a Northwest London hospital Trust, 2014 – 2015 Posters Abstract ID: 3785 - Ahmad R, Castro-Sanchez E, Iwami M, Husson F, Holmes A. Knowledge, perceptions and decision making: What matters to patients? Abstract ID: 3798 - Record C, Gilchrist M, Patel D, Jiao L. Infection prevention in splenectomy patients: An audit of practice in a regional hepatobiliary centre Abstract ID: 3799 - Turnbull A, Moore L, Azadian B. To PPE or not to PPE Abstract ID: 3858 - Batten L, Holmes A, Otter J, Castro-Sanchez E. Estimating the isolation burden if overseas residents are pre-emptively isolated during CRE admission screening Abstract ID: 3859 - Mookerjee S, Sullivan J, Davies F, Donaldson H, Brannigan E, Holmes A, Otter J. Real-time surveillance of carbapenem-resistant Enterobacteriaceae (CRE) using live microbiology culture data in a North-West London Hospital Trust, 2014–2015 Abstract ID: 3861 - Alexander M, Mookerjee S, Nelson D, Holmes A, Otter J. An audit of single room capacity for isolation at a London hospital Trust   Abstract ID: 3862 - Galletly T, Bateman A, Brannigan E, Holmes A, Otter J. Thematic analysis of post 48-hour bloodstream infections: What did we learn? Abstract ID: 3863 - Acharya A , Samarasinghe D , Singleton J, Brannigan E, Galletly T, Donaldson H, Holmes A, Otter J. Pilot evaluation of environmental hygiene using fluorescent markers and microbiological cultures Abstract ID: 3864 - Gilchrist M , Galletly T, Brannigan E, Holmes A, Otter J. How much Clostridium difficile is preventable? Abstract ID: 3867 - Goldberg S, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Girdham S, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth J, Otter J. Poor sensitivity of perineal compared with rectal swabs for detecting ESBL Enterobacteriaceae

Alison Holmes, Jonathan Otter Risk factors for patients with carbapenemase-producing Enterobacteriaceae (CPE) at Imperial College Healthcare NHS Trust, 2014 – 2015 Siddharth Mookerjee, Jonathan Sullivan, Frances Davies, Hugo Donaldson, Eimear Brannigan, Alison Holmes, Jonathan Otter Jon.Otter@imperial.nhs.uk jonotter.net